Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K232216Substantially Equivalent

Hemoblock_S (Prescription); Hemoblock_S (OTC)

Incore Co., Ltd., Daegu, KR / Traditional, Substantially Equivalent

K232216 is the FDA 510(k) clearance record for Hemoblock_S (Prescription); Hemoblock_S (OTC), cleared for Incore Co., Ltd. on under FDA product code QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics). FDA's definition for product code QSY reads: "To temporarily control bleeding and cover external wounds". FDA records list 6 510(k) clearances for Incore Co., Ltd., from to . As of , FDA records show no recalls naming K232216.

Clearance record

Decision date
Received
(268 days to decision)
Product code
QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device class
Unclassified
Review panel
Unknown
Applicant
Incore Co., Ltd. 11, Hyeoksin-Daero 78-Gil, Dong-Gu, Daegu, KR
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QSY

Trailing 12 months
4 clearances under product code QSY in the twelve months to October 2026, December 2025 the highest month at 2.
Show the numbers
Monthly 510(k) clearances under FDA product code QSY, trailing twelve months
MonthClearances
November 20250
December 20252
January 20260
February 20261
March 20260
April 20261
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260